Pep2Tango Therapeutics
Potomac, US · Founded 2021 · Delaware corporation · 1 known investors
Founders & leadership
CR
Cristina RondinoneNamed on SEC filing
Board
MK
Mickey KimBoard director
CR
SG
Soumitra GhoshBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$16.7M disclosed across 1 round · 2024
▶$16.7MraisedNov 2024 · 12 investors · BiotechnologyRule 506(b)
▶$16.7MraisedNov 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mickey KimDirector
- Cristina RondinoneExecutive Officer, Director
- Carlo RizzutoDirector
- Soumitra GhoshDirector
- Offering amount
- $16.7M
- Amount sold
- $16.7M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Pep2Tango Therapeutics's investors?
- Pep2Tango Therapeutics's investors include Versant Ventures.
- How much funding has Pep2Tango Therapeutics raised?
- Pep2Tango Therapeutics has disclosed $16.7M raised across 1 round.
- Where is Pep2Tango Therapeutics headquartered?
- Pep2Tango Therapeutics is headquartered in Potomac, US.